Brett Giffin
Corporate Officer/Principal chez T2 BIOSYSTEMS, INC.
Fortune : 231 $ au 31/03/2024
Profil
Brett Giffin currently works at T2 Biosystems, Inc., as Chief Commercial Officer from 2021.
Mr. Giffin also formerly worked at Fibronostics US, Inc., as Chief Executive Officer, 3si Systems LLC, as Chief Executive Officer, International Technidyne Corp., as Vice President-Marketing & Business Development, and Accriva Diagnostics, Inc., as Chief Commercial Officer.
Mr. Giffin received his undergraduate degree from Christopher Newport University, undergraduate degree from The College of William & Mary, and Masters Business Admin degree from the University of Phoenix.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
T2 BIOSYSTEMS, INC.
0,00% | 20/02/2024 | 77 ( 0,00% ) | 231 $ | 31/03/2024 |
Postes actifs de Brett Giffin
| Sociétés | Poste | Début |
|---|---|---|
| T2 BIOSYSTEMS, INC. | Corporate Officer/Principal | 08/11/2021 |
Anciens postes connus de Brett Giffin
| Sociétés | Poste | Fin |
|---|---|---|
| 3si Systems LLC | Chief Executive Officer | - |
Fibronostics US, Inc.
 Fibronostics US, Inc. Packaged SoftwareTechnology Services Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL. | Chief Executive Officer | - |
Accriva Diagnostics, Inc.
 Accriva Diagnostics, Inc. Medical/Nursing ServicesHealth Services Accriva Diagnostics, Inc. provides point-of-care cardiovascular diagnostics services. It products include avoximeter whole blood oximeter, avoximeter whole blood co-oximeter, data management and connectivity, hemochron response whole blood coagulation system, hemochron signature elite whole blood microcoagulation, inrhythm whole blood system, surgicutt bleeding time, tenderfoot heel incision, tenderlett finger incision device and verifynow system platelet reactivity test. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
International Technidyne Corp.
 International Technidyne Corp. Medical SpecialtiesHealth Technology International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ. | Sales & Marketing | - |
Formation de Brett Giffin
| Christopher Newport University | Undergraduate Degree |
| The College of William & Mary | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| T2 BIOSYSTEMS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
International Technidyne Corp.
International Technidyne Corp. Medical SpecialtiesHealth Technology International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ. | Health Technology |
Accriva Diagnostics, Inc.
Accriva Diagnostics, Inc. Medical/Nursing ServicesHealth Services Accriva Diagnostics, Inc. provides point-of-care cardiovascular diagnostics services. It products include avoximeter whole blood oximeter, avoximeter whole blood co-oximeter, data management and connectivity, hemochron response whole blood coagulation system, hemochron signature elite whole blood microcoagulation, inrhythm whole blood system, surgicutt bleeding time, tenderfoot heel incision, tenderlett finger incision device and verifynow system platelet reactivity test. The company is headquartered in San Diego, CA. | Health Services |
Fibronostics US, Inc.
Fibronostics US, Inc. Packaged SoftwareTechnology Services Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL. | Technology Services |
| 3si Systems LLC |
